Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related LXRX
Every Biotech Catalyst Wedbush Is Watching In 2016
Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial, Met Primary Endpoint
Related ARIA
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors
Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 10.70% to $2.07 in the pre-market session. Lexicon Pharmaceuticals reported that it has received "Fast Track" status from the FDA for the development of LX1033.

Ariad Pharmaceuticals (NASDAQ: ARIA) added 3.48% to $19.59 in the pre-market session. ARIAD Pharmaceuticals reported that the FDA has granted accelerated approval of Iclusig™ (ponatinib).

American Capital Agency (NASDAQ: AGNC) moved up 2.85% to $31.06 in the pre-market session. American Capital Agency declared a Q4 cash dividend of $1.25 per common share.

Sprint Nextel (NYSE: S) soared 2.16% to $5.67 in the pre-market trading. Sprint will acquire the approximately 50% stake in Clearwire (NASDAQ: CLWR) it does not currently own for $2.97 per share.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (AGNC + ARIA)

Get Benzinga's Newsletters